Study protocol: baby-OSCAR trial: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies, a multicentre, masked, randomised placebo-controlled parallel group trial
<p><strong>BACKGROUND:</strong> The question of whether to treat patent ductus arteriosus (PDA) early or wait until symptoms appear remains high on the research agenda for neonatal medicine. Around 7000 extremely preterm babies under 29 weeks' gestation are born in...
Auteurs principaux: | Gupta, S, Juszczak, E, Hardy, P, Subhedar, N, Wyllie, J, Kelsall, W, Sinha, S, Johnson, S, Roberts, T, Hutchison, E, Pepperell, J, Linsell, L, Bell, JL, Stanbury, K, Laube, M, Edwards, C, Field, D, ‘The Baby-OSCAR Collaborative Group’ |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
BMC
2021
|
Documents similaires
-
Study protocol: baby-OSCAR trial: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies, a multicentre, masked, randomised placebo-controlled parallel group trial
par: Samir Gupta, et autres
Publié: (2021-02-01) -
Correction to: Study protocol: baby-OSCAR Trial: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies, a multicentre, masked, randomised placebo-controlled parallel group trial
par: Samir Gupta, et autres
Publié: (2021-07-01) -
Trial of selective early treatment of patent ductus arteriosus with ibuprofen
par: Gupta, S, et autres
Publié: (2024) -
Baby-OSCAR: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies—a statistical analysis plan for short-term outcomes
par: Bell, JL, et autres
Publié: (2021) -
Baby-OSCAR: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies—a statistical analysis plan for short-term outcomes
par: Jennifer L. Bell, et autres
Publié: (2021-05-01)